TruLeaf Medical, a medical device startup company, is presenting a breakthrough solution for mitral valve replacement.
Founded in 2017, our mission is to bring an ultimately user-friendly, Transfemoral Mitral Valve Replacement (TMVR) solution that will be available for every cardiologist and every Mitral Regurgitation (MR) patient. Our focus is on procedure simplicity, safety and efficacy. 
TruLeaf's approach will bring the solution for the long-lasting problem in an elegant, original and safe way.
_____________________
What is MR?
Mitral regurgitation (MR) is a condition in which the valve doesn't close properly. Blood leaks back into the left atrium, decreasing blood flow to the body and causing the left atrial pressure to rise.
What is TMVR?
Transcatheter Mitral Valve Replacement (TMVR) is a cardiac intervention method in which the dysfunctional mitral valve is  replaced by a prosthetic valve, using a catheter-based approach. 
_____________________
More updates are coming in the near future. Follow us and visit our website to learn more!

Biotechnology

Health Care

Health Diagnostics

Medical Devices

Therapeutics

TruLeaf Medical

TruLeaf Medical's headquarters in Caesarea, Israel

Description

People (1)

Sagiv Shmilovich

Jobs